September 14, 2015 |
For researchers, physicians - and patients - prostate cancer has always been among the most maddening and elusive of foes. The third-most common cancer in the United States, behind breast and lung cancers, its course is less predictable than either. It can remain dormant in a man's body until he dies decades later from something else. Or it can spread aggressively and kill. The riddle has been how to tell one cancer from another. Now researchers at Thomas Jefferson University and elsewhere think they are coming closer to solving it through increasingly sophisticated genetic studies.
February 1, 2012 |
ASSOCIATED PRESS A warning to men considering a pricey new treatment for prostate cancer called proton therapy: Research suggests it might have more side effects than traditional radiation does. A study of Medicare records found that men treated with proton beams later had one-third more bowel problems, such as bleeding and blockages, than men given conventional radiation. This is an observational study, so it is not definitive, but it is one of the largest to compare those treatments.
November 26, 2012 |
Question: I recently had a prostate biopsy, which showed a small area of cancer. My urologist discussed the option of close surveillance, with periodic biopsies and regular PSA blood testing. I'm 65 years old and otherwise in great health. Do you think it's better to treat the cancer or just watch it? Answer: In the case of early prostate cancer like you have, "active surveillance" is a reasonable approach. The downsides are the uncertainty of the disease course and the anxiety of living with prostate cancer.
October 2, 2013 |
Decades after lumpectomy became a standard option for women with breast cancer, men are seeking a similarly targeted approach to prostate cancer, one that gets rid of the tumor while preserving the organ. This sensible tack has lagged in prostate cancer for many reasons, starting with the fact that the golf-ball-size gland is inaccessible. It lies deep within the pelvic cavity, surrounded by sensitive structures that are vital to sexual and urinary health. Now, however, an array of technologies is enabling doctors to visualize and zap away prostate malignancies.
April 9, 2011 |
Steve Lavin , who revived St. John's basketball in his first season with the Red Storm, has prostate cancer, but his doctor expects him to keep coaching and make a complete recovery. Lavin, 46, said in a statement yesterday he was diagnosed in September and was told he could delay treatment until after the season. He will begin treatment in the coming weeks. The statement did not say how he will treated. "My family feels fortunate that through annual health exams, we detected my condition at an early stage," Lavin said.
April 21, 1992 |
When Jim Ferree won the PGA Seniors Bell Atlantic Classic last May, just one month shy of his 60th birthday, he used words like "cherish" and "savor" to describe the victory, only the third of a professional career that has spanned five decades. "You never know if it'll be your last," Ferree said that day. "A lot of guys my age are dead. " George Lanning, a 58-year-old fellow Senior, had just died while convalescing from open-heart bypass surgery, and that clearly had an effect on Ferree.
May 23, 2012 |
Amid the many messages you will hear about screening for prostate cancer in the coming days, I hope these stand out: There is at best a small potential benefit from prostate cancer screening, and there are substantial known harms. We need a better test, and we need better treatment options. The panel I chair, the U.S. Preventive Services Task Force, has just issued a recommendation against screening men of any age for prostate cancer using the prostate-specific antigen, or PSA, blood test.
October 4, 2012 |
Prostate cancer is especially tough on African Americans. They are about 50 percent more likely than white men to get the disease and twice as likely to die of it. The Prostate Cancer Foundation wants to help research institutions in Philadelphia take the lead in figuring out why, the foundation's founder and co-chair, Michael Milken, said Tuesday evening during the group's 10th annual fund-raiser in Philadelphia. Milken said he wonders, "What can we learn from this that would not only help them but will help all men on the planet?"
December 16, 2003 |
The disease that Secretary of State Colin L. Powell is now fighting is as complex and confounding as it is common. Prostate cancer strikes one in six men, and is second only to lung cancer as a cause of cancer death among U.S. men. Last year, it was diagnosed in 190,000, and killed more than 30,000, the majority of them over age 65. The causes of prostate cancer remain unclear, although certain risk factors are known, including age, family...
August 11, 2013 |
Holy mackerel! Or, in light of a new study, "unholy" might be more appropriate. Omega-3 fatty acids derived from oil in fatty fish like mackerel, tuna, and salmon are still endorsed by doctors for controlling blood fats in heart disease. But when it comes to preventing cancer, the verdict has gotten murky. A study published in July found omega-3 may raise the risk of prostate cancer. "This is not a happy finding," said Theodore Brasky, who led the study at the Ohio State University Comprehensive Cancer Center.